Other

Share-based compensation expense related to employee stock plans

Insmed Share-based compensation expense related to employee stock plans increased by 17.2% to $45.75M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.5%, from $39.26M to $45.75M. Over 4 years (FY 2021 to FY 2025), Share-based compensation expense related to employee stock plans shows an upward trend with a 35.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026

How to read this metric

Higher levels indicate significant use of equity as a component of employee compensation, which can lead to shareholder dilution.

Detailed definition

This metric represents the non-cash expense recognized in the equity section of the balance sheet related to share-based...

Peer comparison

Standard equity adjustment for companies utilizing stock-based incentive plans.

Metric ID: other_adjustments_to_additional_paid_in_capital_sharebas_9e4bb6

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$11.74M$12.23M$11.52M$12.82M$14.26M$15.65M$14.95M$16.44M$18.36M$19.99M$19.98M$21.45M$23.29M$25.55M$26.55M$39.26M$42.98M$31.43M$39.04M$45.75M
QoQ Change+4.2%-5.8%+11.3%+11.2%+9.8%-4.5%+10.0%+11.7%+8.9%-0.1%+7.3%+8.6%+9.7%+3.9%+47.9%+9.5%-26.9%+24.2%+17.2%
YoY Change+21.5%+28.0%+29.8%+28.2%+28.8%+27.7%+33.7%+30.5%+26.8%+27.8%+32.9%+83.0%+84.6%+23.0%+47.0%+16.5%
Range$11.52M$45.75M
CAGR+33.2%
Avg YoY Growth+35.6%
Median YoY Growth+28.5%
Current Streak2 quarters growth

Frequently Asked Questions

What is Insmed's share-based compensation expense related to employee stock plans?
Insmed (INSM) reported share-based compensation expense related to employee stock plans of $45.75M in Q1 2026.
How has Insmed's share-based compensation expense related to employee stock plans changed year-over-year?
Insmed's share-based compensation expense related to employee stock plans increased by 16.5% year-over-year, from $39.26M to $45.75M.
What is the long-term trend for Insmed's share-based compensation expense related to employee stock plans?
Over 4 years (2021 to 2025), Insmed's share-based compensation expense related to employee stock plans has grown at a 35.0% compound annual growth rate (CAGR), from $46.02M to $152.71M.
What does share-based compensation expense related to employee stock plans mean?
The accounting cost of employee stock-based compensation.